SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024511
Filing Date
2021-05-06
Accepted
2021-05-06 07:14:35
Documents
56
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arav-10q_20210331.htm 10-Q 1122828
2 EX-31.1 arav-ex311_6.htm EX-31.1 17351
3 EX-31.2 arav-ex312_8.htm EX-31.2 17166
4 EX-32.1 arav-ex321_9.htm EX-32.1 8336
5 EX-32.2 arav-ex322_7.htm EX-32.2 8208
  Complete submission text file 0001564590-21-024511.txt   4357611

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arav-20210331.xml EX-101.INS 744329
7 XBRL TAXONOMY EXTENSION SCHEMA arav-20210331.xsd EX-101.SCH 41833
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20210331_cal.xml EX-101.CAL 29211
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20210331_def.xml EX-101.DEF 124552
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20210331_lab.xml EX-101.LAB 342607
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20210331_pre.xml EX-101.PRE 249830
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 21895765
SIC: 2834 Pharmaceutical Preparations